Full-Time

Regional Director

Prisma Health

Posted on 9/11/2025

LabCorp

LabCorp

10,001+ employees

Global life sciences R&D services

No salary listed

Greenville, SC, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Bachelor's degree in Biology, Chemistry, Medical Technology or a related life science; advanced degree preferred
  • Minimum 5 years of clinical laboratory experience within a supervisory or management role
  • Experience leading a microbiology, anatomic pathology, and clinical pathology dept preferred
  • ASCP, AMT, or any other relevant laboratory certifications as MLS or MT
  • Proficient in laboratory knowledge and how to effectively manage a clinical laboratory
  • Prior experience in a high volume, large hospital environment
  • Familiar with new laboratory instrumentation and equipment automation
  • Strong working knowledge of supply chain operations and expense control
  • Ability to communicate with a heavy customer focus when working with client leadership
  • Strong working knowledge of CLIA, CAP and relevant state regulations
  • Understanding of laboratory operations as well as policies and procedures
  • Proven success in training and developing both technical and non-technical employees
  • Strong demonstrated leadership capabilities including: emotional intelligence, excellent listening, verbal and written communication and interpersonal skills; ability to manage the performance of others and provide developmental coaching/feedback and mentoring
  • Ability to problem solve and provide solutions under minimal supervision
  • Able to balance the needs of the business with the needs of the employees
  • Proficient with Laboratory Information Systems and Microsoft Office
  • Strong communication skills; both written and verbal
  • High level of attention to detail with strong organizational skills
Responsibilities
  • Lead and direct the hospital laboratories within the market to ensure quality results, proper staffing, financial vitality, and foster a team environment
  • Ensure adherence and implementation of laboratory policies and procedures for sites within the designated market
  • Work closely with hospital administration and lab leadership in maintaining financial objectives and understand/explain variances of laboratories within the market
  • Ensure laboratories within the market are performing within established metrics – understand root cause and implement process improvements when necessary
  • Partner with Quality and oversee the implementation of new test methods and procedures at hospitals within the market
  • Work closely with Medical Directors, Professional Support Leaders, and Health System Leadership to ensure the laboratories are meeting the expectations of the providers and patients
  • Resolve client inquiries and operational issues in a timely manner by consulting with the Medical Director, Technical Director, QA, other laboratory managers, discipline directors, laboratory managers or corporate operations
  • Maintain compliance with corporate, state and federal regulatory requirements (CAP, CLIA, State, ISO, etc.) related to personnel safety and quality of laboratory testing as well as professional conduct
  • Serve as the laboratory liaison and a partner for other health system departments – promote communication and teamwork
  • Ensure effective communication with leadership, clients, corporate operations, as well as direct reports, departmental staff, and inter-departmental staff
  • Assist in budget preparation and expense management for sites within the designated market
  • Promote a culture of process improvement, professional growth, continuous learning
  • Conduct laboratory meetings to ensure communication of laboratory performance, process changes, and to promote a positive interaction between laboratory leaders
  • Investigate deviations from established procedures to ensure effective corrective action
  • Maintain a clean and safe work environment
  • Be an available resource to support the team as needed
Desired Qualifications
  • Experience leading a microbiology, anatomic pathology, and clinical pathology dept preferred
  • Previous experience managing multiple locations is highly preferred

Labcorp provides end-to-end R&D services for life sciences and agricultural clients, including crop protection, with testing and regulatory support. It runs physicochemical analyses, safety assessments, and inhalation toxicology studies using specialized labs to evaluate inhaled substances. It differentiates itself with a global footprint and an integrated set of services across the product lifecycle, including regulatory submissions. Its goal is to help clients bring safe, effective products to market efficiently by applying rigorous science and scalable testing.

Company Size

10,001+

Company Stage

IPO

Headquarters

Burlington, Vermont

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.54B, up 5.8%, raising full-year guidance to $14.73B.
  • AI Alzheimer's platform validates spring 2026, expands to oncology and cardiometabolic areas.
  • Optum.ai partnership automates lab workflows and enhances patient engagement.

What critics are saying

  • Quest Diagnostics outgrows Labcorp at 9.2% versus 5.8%, eroding diagnostics share in 6-12 months.
  • NeoGenomics seizes oncology volume with 11.1% growth, hitting Labcorp's specialty testing now.
  • Tempus commoditizes Labcorp's AI platform with superior EHR integration in 24 months.

What makes LabCorp unique

  • Labcorp's AI platform with AWS and Datavant analyzes Alzheimer's data in minutes using deidentified lab datasets.
  • Labcorp holds first FDA clearance for rapid fentanyl urine test in emergency settings.
  • Labcorp's Plasma Detect Genome MRD assesses NSCLC recurrence risk via whole-genome sequencing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Employee Stock Purchase Plan

Company News

360Dx
May 5th, 2026
Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC.

Fox Chase Cancer Center, Labcorp collaborate on clinical trial for Plasma Detect Genome MRD in NSCLC. NEW YORK - Temple Health's Fox Chase Cancer Center and Laboratory Corporation of America announced Tuesday a clinical trial collaboration to evaluate the use of Labcorp's whole-genome sequencing Plasma Detect Genome MRD to assess the risk of recurrence in patients with early stage non-small cell lung cancer (NSCLC). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

Resonate Group
Apr 15th, 2026
Labcorp launches rapid fentanyl test with 48-hour detection window.

Labcorp launches rapid fentanyl test with 48-hour detection window. * April 15, 2026 While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the U.S., and now Labcorp is launching a new test designed to detect the drug's use for up to 48 hours after exposure. Fields (*) Mark are Required

PR Newswire
Apr 14th, 2026
Labcorp launches AI-powered platform with AWS and Datavant to accelerate Alzheimer's research

Labcorp has launched an AI-powered real-world data platform to accelerate Alzheimer's disease research, developed in collaboration with Amazon Web Services and Datavant. The platform aims to generate insights in minutes that previously required months of data analysis. The system combines Labcorp's diagnostic and genomic datasets with medical claims data, using AWS AI services including Amazon Bedrock and Amazon SageMaker. It enables researchers to identify patient cohorts, track disease progression and measure treatment effectiveness across diverse populations using deidentified healthcare data. With over 7.2 million Americans living with Alzheimer's and annual care costs exceeding $380 billion in the US, the platform addresses traditional challenges of fragmented data and lengthy preparation times. Initial validation will complete in spring 2026, with plans to expand into inflammatory diseases, cardiometabolic conditions, women's health and oncology.

360Dx
Apr 13th, 2026
Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics.

Labcorp, CHOP to develop, commercialize specialty pediatric diagnostics. NEW YORK - Laboratory Corporation of America and Children's Hospital of Philadelphia (CHOP) on Monday announced a strategic collaboration to accelerate the development of and access to specialized pediatric diagnostics. Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

360Dx
Mar 20th, 2026
In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more.

In brief this week: Labcorp, guardant Health, waters, fulgent genetics, more. NEW YORK - Laboratory Corporation of America this week said it has completed its acquisition of select assets of Crouse Health's Laboratory Alliance of Central New York's laboratory business. The two firms also have entered into a deal for Crouse Health to manage the daily operations of its inpatient lab, while Labcorp will take over operations of the lab alliance's 12 patient service centers. It said in a statement that the deal will improve access to high-quality, affordable diagnostic services in Central New York by offering patients and providers Labcorp's expanded testing menu, data, and digital tools. To read the full story... What's Popular?

INACTIVE